84 related articles for article (PubMed ID: 22384635)
21. O-GlcNAc cycling enzymes control vascular development of the placenta by modulating the levels of HIF-1α.
Yang YR; Jang HJ; Lee YH; Kim IS; Lee H; Ryu SH; Suh PG
Placenta; 2015 Oct; 36(10):1063-8. PubMed ID: 26286378
[TBL] [Abstract][Full Text] [Related]
22. [Expression of E-cadherin and beta1-integrin mRNA in endometrial cancer].
Wójcik-Krowiranda K; Forma E; Zaczek A; Bryś M; Anna MK; Bieńkiewicz A
Ginekol Pol; 2013 Nov; 84(11):910-4. PubMed ID: 24455846
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers.
Jin F; Dowdy SC; Xiong Y; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Feb; 96(2):531-8. PubMed ID: 15661247
[TBL] [Abstract][Full Text] [Related]
24. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
St-Germain ME; Gagnon V; Parent S; Asselin E
Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
[TBL] [Abstract][Full Text] [Related]
25. O-GlcNAcase Expression is Sensitive to Changes in O-GlcNAc Homeostasis.
Zhang Z; Tan EP; VandenHull NJ; Peterson KR; Slawson C
Front Endocrinol (Lausanne); 2014; 5():206. PubMed ID: 25520704
[TBL] [Abstract][Full Text] [Related]
26. Icaritin inhibits endometrial carcinoma cells by suppressing O-GlcNAcylation of FOXC1.
Wang Y; Wang G; Liu Y; Yang F; Zhang H; Kong Y
Phytomedicine; 2023 Nov; 120():155062. PubMed ID: 37683586
[TBL] [Abstract][Full Text] [Related]
27. Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-κB signaling.
Yang YR; Kim DH; Seo YK; Park D; Jang HJ; Choi SY; Lee YH; Lee GH; Nakajima K; Taniguchi N; Kim JM; Choi EJ; Moon HY; Kim IS; Choi JH; Lee H; Ryu SH; Cocco L; Suh PG
Oncotarget; 2015 May; 6(14):12529-42. PubMed ID: 25915426
[TBL] [Abstract][Full Text] [Related]
28. O-GlcNAcylation of the human epidermal growth factor receptor.
Stateva SR; Villalobo A
Org Biomol Chem; 2015 Aug; 13(30):8196-204. PubMed ID: 26108188
[TBL] [Abstract][Full Text] [Related]
29. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
30. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
Goldberg H; Whiteside C; Fantus IG
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
[TBL] [Abstract][Full Text] [Related]
31. Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines.
Steenackers A; Olivier-Van Stichelen S; Baldini SF; Dehennaut V; Toillon RA; Le Bourhis X; El Yazidi-Belkoura I; Lefebvre T
Front Endocrinol (Lausanne); 2016; 7():46. PubMed ID: 27252680
[TBL] [Abstract][Full Text] [Related]
32. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
33. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
[TBL] [Abstract][Full Text] [Related]
34. Oestrogen receptor beta expression and depth of myometrial invasion in human endometrial cancer.
Takama F; Kanuma T; Wang D; Kagami I; Mizunuma H
Br J Cancer; 2001 Feb; 84(4):545-9. PubMed ID: 11207052
[TBL] [Abstract][Full Text] [Related]
35. Alteration of O-GlcNAcylation affects serine phosphorylation and regulates gene expression and activity of pyruvate kinase M2 in colorectal cancer cells.
Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2015 Oct; 34(4):1933-42. PubMed ID: 26252736
[TBL] [Abstract][Full Text] [Related]
36. Frequent inactivation of RUNX3 in endometrial carcinoma.
Yoshizaki T; Enomoto T; Fujita M; Ueda Y; Miyatake T; Fujiwara K; Miyake T; Kimura T; Yoshino K; Kimura T
Gynecol Oncol; 2008 Sep; 110(3):439-44. PubMed ID: 18572225
[TBL] [Abstract][Full Text] [Related]
37. Proteomic Analysis Reveals Aberrant O-GlcNAcylation of Extracellular Proteins from Breast Cancer Cell Secretion.
Netsirisawan P; Chokchaichamnankit D; Srisomsap C; Svasti J; Champattanachai V
Cancer Genomics Proteomics; 2015; 12(4):201-9. PubMed ID: 26136220
[TBL] [Abstract][Full Text] [Related]
38. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
Caldwell SA; Jackson SR; Shahriari KS; Lynch TP; Sethi G; Walker S; Vosseller K; Reginato MJ
Oncogene; 2010 May; 29(19):2831-42. PubMed ID: 20190804
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients.
Kamigaito T; Okaneya T; Kawakubo M; Shimojo H; Nishizawa O; Nakayama J
Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):18-22. PubMed ID: 24366413
[TBL] [Abstract][Full Text] [Related]
40. Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status.
Milde-Langosch K; Goemann C; Methner C; Rieck G; Bamberger AM; Löning T
Br J Cancer; 2001 Aug; 85(4):546-51. PubMed ID: 11506494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
